Eiko Lifesciences Share Price
51.90+0.87 (+1.70%)
-9.64% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SOLARINDS-ANSE
PIDILITIND-ANSE
SRF-ANSE
FLUOROCHEM-ANSE
GODREJIND-ANSE
DEEPAKNTR-ANSE
AETHER-ANSE
AARTIIND-ANSE
FINEORG-ANSE
EIKO-XNSE
Eiko Lifesciences Share Price
51.90+0.87 (+1.70%)
-9.64% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 131% | 40% |
| - | - | - | 130% |
| - | -6% | -4% | -11% |
| -17% | -17% | -25% | 9% |
Peer Comparison
Symbol
SOLARINDS-A
PIDILITIND-A
SRF-A
FLUOROCHEM-A
NAVINFLUOR-A
GODREJIND-A
DEEPAKNTR-A
AETHER-A
AARTIIND-A
FINEORG-A
EIKO-X
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 19,692.8 | ₹177542 Cr | 78.44 | 68.18 | 283.5 | ₹1678 Cr |
| 1,520.9 | ₹154308 Cr | 57.49 | 6.03 | 30.24 | ₹2449 Cr |
| 2,438.65 | ₹71461 Cr | 31.31 | 17.18 | 106.98 | ₹1835 Cr |
| 4,502.9 | ₹48887 Cr | 72 | 22.09 | 97.5 | ₹577 Cr |
| 8,608.65 | ₹43801 Cr | 48.1 | 52.48 | 208.91 | ₹664 Cr |
| 977.25 | ₹32083 Cr | 27.29 | 8.44 | 50.37 | ₹1241 Cr |
| 1,543.3 | ₹20747 Cr | 19.53 | 29.15 | 96.58 | ₹551 Cr |
| 1,512.45 | ₹19934 Cr | 79.98 | 5.12 | 24.71 | ₹219 Cr |
| 439.45 | ₹15937 Cr | 26.83 | 4.67 | 29.86 | ₹419 Cr |
| 5,121.65 | ₹15598 Cr | 32.38 | 49.62 | 176.69 | ₹417 Cr |
| 51.9 | ₹76 Cr | 14.84 | 1.05 | 4.13 | ₹4 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 | Jun 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹17 Cr | ₹18 Cr | ₹12 Cr | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹7 Cr | ₹8 Cr | ₹11 Cr | ₹84 L | ₹56 L | ₹62 L | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹88 L | ₹1 Cr | ₹1 Cr |
| ₹41 L | ₹13 L | ₹32 L | ₹26 L | ₹27 L | ₹23 L | ₹9 L | ₹13 L | ₹26 L | ₹1 L | ₹5 L | -₹4 L | ₹1 L | ₹5 L | ₹3 L | ₹3 L | ₹0 | ₹2 L | ₹1 L |
| ₹17 Cr | ₹18 Cr | ₹12 Cr | ₹12 Cr | ₹11 Cr | ₹12 Cr | ₹8 Cr | ₹8 Cr | ₹11 Cr | ₹85 L | ₹61 L | ₹58 L | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹88 L | ₹1 Cr | ₹1 Cr |
| ₹15 Cr | ₹16 Cr | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹10 Cr | ₹7 Cr | ₹8 Cr | ₹11 Cr | ₹93 L | ₹46 L | ₹2 Cr | ₹5 Cr | ₹6 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹73 L | ₹55 L | ₹66 L | -₹4 L | ₹18 L | -₹96 L | -₹1 Cr | -₹2 Cr | -₹39 L | -₹33 L | -₹12 L | -₹15 L | -₹9 L |
| ₹13 L | ₹12 L | ₹7 L | ₹10 L | ₹5 L | ₹7 L | ₹3 L | ₹4 L | ₹3 L | ₹10 L | ₹70,000 | ₹3 L | ₹8 L | ₹6 L | ₹7 L | ₹15 L | ₹2 L | ₹5 L | ₹4 L |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹54 L | ₹35 L | ₹46 L | -₹18 L | ₹14 L | -₹1 Cr | -₹1 Cr | -₹2 Cr | -₹50 L | -₹60 L | -₹18 L | -₹24 L | -₹18 L |
| ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹40 L | ₹26 L | ₹35 L | -₹13 L | ₹10 L | -₹74 L | -₹1 Cr | -₹1 Cr | -₹37 L | -₹45 L | -₹14 L | -₹17 L | -₹13 L |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|
| — | — | — | — | — |
| ₹14 Cr | ₹14 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| ₹4 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹50 Cr | ₹43 Cr | -₹87 L | ₹1 Cr | ₹2 Cr |
| ₹50 Cr | ₹43 Cr | -₹87 L | ₹1 Cr | ₹2 Cr |
| ₹69 Cr | ₹57 Cr | ₹3 Cr | ₹5 Cr | ₹6 Cr |
| ₹1 Cr | ₹22 L | -₹2 Cr | -₹12 L | ₹22 L |
| ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹42 L | ₹48 L |
| ₹1 Cr | ₹82 L | -₹2 Cr | -₹27 L | ₹3 L |
| ₹4 Cr | ₹3 Cr | -₹2 L | ₹15 L | ₹51 L |
| — | — | — | — | — |
| ₹13 Cr | ₹3 Cr | ₹4 Cr | ₹1 Cr | ₹2 Cr |
| ₹55 L | ₹2 Cr | ₹5 Cr | ₹2 Cr | ₹1 Cr |
| ₹2 Cr | ₹76 L | ₹0 | ₹94 L | ₹1 Cr |
| ₹60 L | ₹40 L | ₹4 L | ₹5 L | ₹6 L |
| ₹15 Cr | ₹6 Cr | ₹9 Cr | ₹4 Cr | ₹5 Cr |
| ₹89 Cr | ₹66 Cr | ₹10 Cr | ₹9 Cr | ₹11 Cr |
| ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
| — | — | — | — | — |
| ₹26 Cr | ₹26 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr |
| ₹4 Cr | ₹3 Cr | ₹93 L | ₹74 L | ₹58 L |
| ₹22 Cr | ₹23 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| ₹15 Cr | ₹7 Cr | ₹10 L | ₹2 Cr | ₹3 Cr |
| ₹15 Cr | ₹7 Cr | ₹10 L | ₹2 Cr | ₹3 Cr |
| ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹5 L | ₹4 L |
| ₹0 | ₹0 | ₹1 Cr | ₹1 Cr | ₹8 L |
| ₹42 Cr | ₹33 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr |
| — | — | — | — | — |
| ₹4 Cr | ₹6 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr |
| ₹20 Cr | ₹11 Cr | ₹1 Cr | ₹86 L | ₹1 Cr |
| ₹14 Cr | ₹12 Cr | ₹2 L | ₹11 L | ₹80 L |
| ₹6 L | ₹23,000 | ₹14 L | ₹31 L | ₹4 L |
| ₹10 Cr | ₹5 Cr | ₹47 L | ₹58 L | ₹57 L |
| ₹47 Cr | ₹33 Cr | ₹5 Cr | ₹4 Cr | ₹6 Cr |
| ₹32 Cr | ₹27 Cr | -₹4 Cr | ₹9 L | ₹1 Cr |
| ₹89 Cr | ₹66 Cr | ₹10 Cr | ₹9 Cr | ₹11 Cr |
| ₹45 | ₹41 | ₹8 | ₹13 | ₹15 |
| ₹45 | ₹41 | ₹8 | ₹13 | ₹15 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|
| ₹7 Cr | ₹3 Cr | -₹5 Cr | -₹100 L | ₹0 |
| ₹22 L | -₹30 L | ₹36 L | ₹34 L | ₹0 |
| -₹4 Cr | ₹32 L | ₹4 Cr | ₹84 L | ₹0 |
| ₹4 Cr | ₹3 Cr | -₹30 L | ₹19 L | ₹0 |
| ₹2 Cr | ₹3 Cr | -₹33 L | ₹16 L | ₹0 |
| -₹9 Cr | -₹11 Cr | -₹71 L | -₹30 L | ₹0 |
| ₹8 Cr | ₹7 Cr | ₹95 L | -₹55 L | ₹0 |
| ₹2 Cr | -₹2 Cr | -₹9 L | -₹69 L | ₹0 |
| ₹12 Cr | ₹13 Cr | ₹11 L | ₹80 L | ₹0 |
| ₹14 Cr | ₹12 Cr | ₹2 L | ₹11 L | ₹0 |
Fundamental Ratios
Consolidated
Standalone
No results found
Eiko Lifesciences Share Price
51.90+0.87 (+1.70%)
-9.64% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 oscillators
RSI
57.79Buy
STOCH %K
82.08Sell
MACD Level(12,26)
0.76Buy
Ultimate Oscillator
41.87Sell
Aroon Oscillator
16.00Sell
BOP
0.23Buy
CCI
117.11Sell
Williams %R
-17.92Sell
Momentum
3.01Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 9
Bearish signals: 0 out of 9 moving averages
EMA 9
50.52Buy
SMA 9
50.57Buy
EMA 21
49.76Buy
SMA 21
49.39Buy
EMA 50
49.01Buy
SMA 50
48.14Buy
EMA 200
49.90Buy
SMA 200
50.15Buy
WMA 20
50.11Buy
Pivot
Pivot
Classic
Resistance 5
64.77
Resistance 4
61.29
Resistance 3
57.81
Resistance 2
54.33
Resistance 1
52.68
Pivot
50.85
Support 1
49.20
Support 2
47.37
Support 3
43.89
Support 4
40.41
Support 5
36.93
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Eiko Lifesciences Share Price
51.90+0.87 (+1.70%)
-9.64% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 39.96% | 39.91% | 39.91% | 37.17% | 37.17% | 37.11% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 60.04% | 60.09% | 60.09% | 62.83% | 62.83% | 62.89% |
Bulk & block deals
Name
Siddhant Laxmikant Kabra
2B Black Bio Llp
Siddhant Laxmikant Kabra
2B Black Bio Llp
Siddhant Laxmikant Kabra
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 25 Jun 2025 | Purchase | 34.83 L | ₹49.06 | 71 K | Bulk | 0.517459 | BSE |
| 27 Mar 2025 | Sell | 70.79 L | ₹51.67 | 1.37 L | Bulk | 0.998477 | BSE |
| 27 Mar 2025 | Purchase | 67.14 L | ₹51.65 | 1.30 L | Bulk | 0.94746 | BSE |
| 18 Feb 2025 | Sell | 34.58 L | ₹50.70 | 68.20 K | Bulk | 0.497045 | BSE |
| 18 Feb 2025 | Purchase | 37.03 L | ₹50.73 | 73 K | Bulk | 0.532035 | BSE |
Insider trading & SAST
Client name
Lenus Finvest Pvt Ltd
Bhavesh Dhirajlal Tanna
Lenus Finvest Pvt Ltd
Siddhant Kabra
2B Black Bio Llp
Siddhant Kabra
Siddhanth Kabra
Bhavesh Tanna
Siddhant Kabra
Siddhant Kabra
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16 Mar 2026 | Promoter | Acquisition | 1.22 | 17.71 | 0 | — | 1.75 L | 24 Feb 2026 | Pref. Allotment | 25,40,472 | SAST | 29(2) | — |
| 16 Mar 2026 | Promoter | Acquisition | 3.14 | 5.86 | 0 | — | 4.50 L | 24 Feb 2026 | Pref. Allotment | 8,40,000 | SAST | 29(1) | — |
| 03 Oct 2025 | Promoter | Acquisition | 0.05 | 17.24 | 0 | — | 7.44 K | 02 Sep 2025 - 03 Sep 2025 | Market | 23,65,472 | SAST | 29(2) | — |
| 07 Jul 2025 | Promoter | Acquisition | 0.51 | 5.83 | 0 | — | 71 K | 25 Jun 2025 | Market | 8,07,650 | SAST | 29(2) | — |
| 21 Apr 2025 | Other | Disposal | 2.5 | 9.95 | 0 | — | 3.46 L | 07 Mar 2025 - 27 Mar 2025 | Market | 13,79,672 | SAST | 29(2) | — |
| 21 Apr 2025 | Promoter | Acquisition | 0.94 | 5.31 | 0 | — | 1.30 L | 27 Mar 2025 | Market | 7,36,650 | SAST | 29(1) | — |
| 17 Apr 2025 | Promoter | Acquisition | 0.31 | 4.38 | 0 | — | 43 K | 25 Mar 2025 | Market | 6,06,650 | SAST | 29(1) | — |
| 09 Apr 2025 | Promoter | Acquisition | 2.08 | 2.6 | 0 | — | 79.14 K | 19 Mar 2018 - 30 Mar 2018 | Market | 99,140 | SAST | 29(1) | — |
| 09 Apr 2025 | Promoter | Acquisition | 0.33 | 4.06 | 0 | — | 47 K | 17 Mar 2025 | Market | 5,63,650 | SAST | 29(1) | — |
| 08 Apr 2025 | Promoter | Acquisition | 0.14 | 3.72 | 0 | — | 20 K | 13 Mar 2025 | Market | 5,16,650 | SAST | 29(1) | — |
Eiko Lifesciences Share Price
51.90+0.87 (+1.70%)
-9.64% past 1 Year
Eiko Lifesciences Limited is carrying the business of an investment company and for that purpose to invest in, acquire, sell, transfer, subscribe for, hold and otherwise deal in and invest
Corporate Actions
Date
Type
Details
Company details
Eiko Lifesciences Share Price
51.90+0.87 (+1.70%)
-9.64% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Eiko Lifesciences Share Price
51.90+0.87 (+1.70%)
-9.64% past 1 Year
News
Eiko Lifesciences informs about newspaper publication
Equity
EIKO
Eiko Lifesciences informs about change in management
Equity
EIKO
Eiko Lifesciences reports Profit after tax of 1.12 Crores, in the March 2026 quarter
Equity
EIKO
Eiko Lifesciences - Quaterly Results
Equity
EIKO
Eiko Lifesciences reports Profit after tax of 94.70 Lakhs, in the December 2025 quarter
Equity
EIKO
Eiko Lifesciences informs about press release
Equity
EIKO
Eiko Lifesciences shines on getting nod to acquire 51% stake in SSM Formulations
Equity
EIKO
Eiko Lifesciences - Quaterly Results
Equity
EIKO
Eiko Lifesciences reports Profit after tax of 81.70 Lakhs, in the September 2025 quarter
Equity
EIKO
Eiko Lifesciences - Quaterly Results
Equity
EIKO
Eiko Lifesciences reports Profit after tax of 69.30 Lakhs, in the June 2025 quarter
Equity
EIKO
Eiko Lifesciences - Quaterly Results
Equity
EIKO
Eiko Lifesciences informs about disclosure
Equity
EIKO
Eiko Lifesciences - Quaterly Results
Equity
EIKO
Eiko Lifesciences reports Profit after tax of 90.10 Lakhs, in the March 2025 quarter
Equity
EIKO
Eiko Lifesciences - Quaterly Results
Equity
EIKO
Eiko Lifesciences - Quaterly Results
Equity
EIKO
Eiko Lifesciences informs about disclosure
Equity
EIKO
Eiko Lifesciences informs about disclosure
Equity
EIKO
Eiko Lifesciences informs about disclosures
Equity
EIKO